Oppenheimer Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Oppenheimer Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,391	Closed	-$244K	–	1141
2020 Q2	$244K	Buy	5,391 +132	+3%	+$5.92K	0.01%	984
2020 Q1	$203K	Buy	5,259 +1,450	+38%	+$66.8K	0.01%	964
2019 Q4	$176K	Buy	3,809 +6	+0.2%	+$260	﹤0.01%	1086
2019 Q3	$155K	Buy	3,803 +2,717	+250%	+$117K	﹤0.01%	1092
2019 Q2	$52K	Sell	1,086 -2,446	-69%	-$129K	﹤0.01%	1371
2019 Q1	$221K	Sell	3,532 -5,730	-62%	-$394K	0.01%	1014
2018 Q4	$553K	Sell	9,262 -467	-5%	-$28K	0.01%	733
2018 Q3	$627K	Buy	9,729 +3,374	+53%	+$188K	0.01%	747
2018 Q2	$286K	Sell	6,355 -707	-10%	-$28.2K	0.01%	958
2018 Q1	$219K	Buy	7,062 +219	+3%	+$7.2K	0.01%	1040
2017 Q4	$226K	Hold	6,843	–	–	0.01%	1012
2017 Q3	$226K	Sell	6,843 -327	-5%	-$11.3K	0.01%	1017
2017 Q2	$240K	Buy	7,170 +6,326	+750%	+$189K	0.01%	982
2017 Q1	$24K	Buy	+844	New	+$20.9K	﹤0.01%	1458

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Oppenheimer Asset Management's BEAT Position: Q3 2020 in Review

Oppenheimer Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 5,391 shares — an estimated $244K sold.

Oppenheimer Asset Management first reported a position in BEAT in Q1 2017 and held it in 14 quarters. The position peaked at $627K in Q3 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

Oppenheimer Asset Management reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
Oppenheimer Asset Management sold 5,391 BioTelemetry, Inc. shares in Q3 2020, an estimated $244K.
Oppenheimer Asset Management first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 14 quarters.
Oppenheimer Asset Management's BioTelemetry, Inc. position peaked at $627K in Q3 2018.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Oppenheimer Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.